Validation of the Pretreatment Neutrophil-Lymphocyte Ratio as a Predictor of Overall Survival in a Cohort of Patients With Pancreatic Ductal Adenocarcinoma

Qiwen Ben(Second Military Medical University), Yaozong Yuan(Ruijin Hospital), Lei Yu(Taiyuan Central Hospital), Wei An(Chengdu University of Traditional Chinese Medicine), Weiyi Wang(Ruijin Hospital), Lifu Wang(Kingmed Diagnostics)
Pancreas
November 25, 2014
10.1097/mpa.0000000000000271
Cited by 58

Related Papers

Plasma MicroRNA Panel to Diagnose Hepatitis B Virus–Related Hepatocellular Carcinoma
|Journal of Clinical Oncology|2011|644
Adjuvant Transarterial Chemoembolization for HBV-Related Hepatocellular Carcinoma After Resection: A Randomized Controlled Study
|Clinical Cancer Research|2018|355
<i>IDH</i> mutations predict longer survival and response to temozolomide in secondary glioblastoma
|Cancer Science|2011|296
Activation of tumor suppressor protein PP2A inhibits KRAS-driven tumor growth
|Journal of Clinical Investigation|2017|200
Acquired temozolomide resistance in MGMT-deficient glioblastoma cells is associated with regulation of DNA repair by DHC2
|Brain|2019|186